US health secretary Robert F Kennedy Jr's changes to federal vaccine policy are prompting medical organisations and several ...

Nirsevimab is effective for protecting infants against respiratory syncytial virus (RSV)-associated lower respiratory tract ...

The Michigan Department of Health and Human Services continues to recommend COVID-19 vaccination for everyone ages 6 months and older, including during pregnancy, despite recent federal changes to ...

The overall level of respiratory disease in the U.S. that includes COVID, flu, and RSV remains “very low.” Emergency room ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

GSK Plc reported better-than-expected profit and raised its estimates for revenue at two key divisions in a report that ...

Professor Margie Danchin addresses declining childhood vaccination rates and vaccine hesitancy through trust-building ...

Businesses, nonprofits, schools, assisted living facilities and other organizations now can schedule an on-site vaccine ...

Vaccinating pregnant women against respiratory syncytial virus (RSV) is linked to a 72% drop in newborns being hospitalized ...

The HHS is betting $500 million on developing a universal flu vaccine that could protect against multiple flu strains.